Banasco, Solito T.
HRN: 18-62-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/19/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
07/19/2026
07/25/2026
IV
750MG
Q24H
HAP
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes